Enanta Pharmaceuticals, Inc. - Common Stock (ENTA)
7.2700
+0.0400 (0.55%)
Enanta Pharmaceuticals is a biotechnology company focused on discovering and developing innovative therapies for infectious diseases and liver diseases
The company specializes in the research and development of small molecule drugs, primarily targeting viral infections such as hepatitis B and hepatitis C, as well as other serious medical conditions. Enanta collaborates with pharmaceutical partners to advance its pipeline of novel antiviral therapeutics, aiming to address unmet medical needs and improve patient outcomes through its scientific expertise and commitment to drug development.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.
Companies Reporting Before The Bell • Madison Square Garden (NYSEMSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Shares of American Eagle Outfitters, Inc. (NYSEAEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the consensus of $1.28 billion. EPS of $0.49 surpassed the consensus of $0.48.
Companies Reporting Before The Bell • Greenland Technologies (NASDAQGTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million.
